Hasil Filter

11778

Total database: 17430
Struktur (SMILES)
8554 (72.6%)
Target
6383 (54.2%)
Genomik
96 (0.8%)
Referensi
11778 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (11778)

Halaman 149 / 236
Migalastat Approved DB05018
small molecule | CAS: 108147-54-2

Fabry disease is a rare, progressive genetic disorder characterized by a defective GLA gene that causes a deficiency in the enzyme alpha-Galactosidase A (alpha-Gal A). This enzyme is responsible for breaking down glycosphingolipid substrate that, when deficie…

Kategori:
Alimentary Tract and MetabolismAlkaloidsAlpha-Galactosidase A (alpha-Gal A) Pharmacological Chaperones +6
Target Protein:
Alpha-galactosidase A
Waktu ParuhThe mean eliminatio…
Vol. DistribusiIn healthy voluntee…
KlirensFollowing ascending…
Genetik -
Miglitol Approved DB00491
small molecule | CAS: 72432-03-2

Miglitol inhibits the breakdown complex carbohydrates into glucose. It is primarily used in diabetes mellitus type 2 for establishing greater glycemic control by preventing the digestion of carbohydrates (such as disaccharides, oligosaccharides, and polysacch…

Kategori:
Alimentary Tract and MetabolismAlkaloidsBlood Glucose Lowering Agents +10
Target Protein:
Lysosomal alpha-glucosidaseNeutral alpha-glucosidase ABNeutral alpha-glucosidase C +1
Waktu ParuhThe elimination hal…
Vol. Distribusi* 0.18 L/kg
Klirens-
Genetik -
Miglustat Approved DB00419
small molecule | CAS: 72599-27-0

Miglustat, commonly marketed under the trade name Zavesca, is a drug used to treat Gaucher disease. It inhibits the enzyme glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids. It is only used for patients who cannot be …

Kategori:
Alimentary Tract and MetabolismAlkaloidsAnti-HIV Agents +14
Target Protein:
Ceramide glucosyltransferase
Waktu ParuhThe effective half-…
Vol. Distribusi-
Klirens-
Genetik -
Milademetan DB15257
small molecule | CAS: 1398568-47-2

Milademetan is under investigation in clinical trial NCT02319369 (Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)).

Kategori:
Heterocyclic Compounds, Fused-Ring
Target Protein:
Coagulation factor VIII
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Milataxel DB12334
small molecule | CAS: 352425-37-7

Milataxel has been used in trials studying the treatment of Mesothelioma.

Kategori:
CyclodecanesCycloparaffinsDiterpenes +2
Target Protein:
Tubulin beta-1 chainTubulin beta chain
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Milatuzumab DB12943
biotech | CAS: 899796-83-9

Milatuzumab has been used in trials studying the treatment of Lupus Nephritis, Multiple Myeloma (MM), GVHD (Acute or Chronic), Myelodysplastic Syndrome, and Chronic Lymphocytic Leukemia, among others.

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +7
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 802539-81-7

Milciclib Maleate is under investigation in clinical trial NCT01301391 (Study of Oral PHA-848125AC in Patients With Malignant Thymoma Previously Treated With Multiple Lines of Chemotherapy).

Kategori:
Heterocyclic Compounds, Fused-Ring
Target Protein:
Cyclin-dependent kinase 2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Milk thistle Approved DB14375
biotech | CAS: 65666-07-1

Milk thistle is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Kategori:
AngiospermsAsteraceaeBiological Products +9
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Milnacipran Approved DB04896
small molecule | CAS: 92623-85-3

Milnacipran is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) and like many agents in this category was originally developed for and continues to be approved and indicated for the treatment of depression [F3928, F3934, A175786, A175951]. F…

Kategori:
Adrenergic AgentsAdrenergic Uptake InhibitorsAgents producing tachycardia +30
Target Protein:
Sodium-dependent serotonin transporterSodium-dependent noradrenaline transporterNMDA receptor
Waktu ParuhThe terminal elimin…
Vol. DistribusiThe mean volume of …
KlirensThe total plasma cl…
Genetik -
Milrinone Approved DB00235
small molecule | CAS: 78415-72-2

Heart failure is a multifactorial condition that affects roughly 1-2% of the adult population. Often the result of long-term myocardial ischemia, cardiomyopathy, or other cardiac insults, heart failure results from an inability of the heart to perfuse periphe…

Kategori:
AminesAminopyridinesCardiac Stimulants Excl. Cardiac Glycosides +12
Target Protein:
cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A
Waktu ParuhMilrinone administe…
Vol. DistribusiMilrinone administe…
KlirensMilrinone administe…
Genetik -
Milvexian DB16233
small molecule | CAS: 1802425-99-5

Milvexian is under investigation in clinical trial NCT03766581 (A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel).

Target Protein:
Coagulation factor XI
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mimopezil DB05520
small molecule | CAS: 180694-97-7

Mimopezil is an acetylcholinesterase (AChE) inhibitor that has demonstrated potential use in the treatment of Alzheimer's disease. Mimopezil is a pro-drug that is rapidly absorbed and converted into huperzine A.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mimosine DB01055
small molecule | CAS: 500-44-7

Mimosine is an antineoplastic alanine-substituted pyridine derivative isolated from _Leucena glauca_.

Kategori:
AlanineAmino AcidsAmino Acids, Peptides, and Proteins +2
Target Protein:
Serine hydroxymethyltransferase, cytosolicC-C motif chemokine 2Tyrosinase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Minaprine Approved DB00805
small molecule | CAS: 25905-77-5

Minaprine is a psychotropic drug which has proved to be effective in the treatment of various depressive states. Like most antidepressants minaprine antagonizes behavioral despair. Minaprine is an amino-phenylpyridazine antidepressant reported to be relative…

Kategori:
Agents that produce hypertensionAgents that reduce seizure thresholdAntidepressive Agents +17
Target Protein:
Amine oxidase [flavin-containing] A5-hydroxytryptamine receptor 2B5-hydroxytryptamine receptor 2A +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mineral oil Approved DB11057
small molecule | CAS: 8042-47-5

Mineral oil, or paraffin oil, is a mixture of higher alkanes from a mineral source, such as petroleum. Petroleum mineral oil is manufactured from crude oils by vacuum distillation to produce several distillates and a residual oil that are then further refined…

Kategori:
Alimentary Tract and MetabolismBasic Ointments and ProtectantsDermatologicals +5
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Minnelide DB17309
small molecule | CAS: 1254702-87-8

Deskripsi belum tersedia.

Kategori:
Alkylating DrugsAntineoplastic AgentsAntineoplastic Agents, Alkylating +6
Target Protein:
Heat shock 70 kDa protein 1BHeat shock 70 kDa protein 1A
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 1254885-39-6

Deskripsi belum tersedia.

Kategori:
Alkylating DrugsAntineoplastic AgentsAntineoplastic Agents, Alkylating +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Minocycline Approved DB01017
small molecule | CAS: 10118-90-8

Minocycline was first described in the literacture in 1966.[A190681] It is a second generation tetracycline antibiotic that is active against gram-negative and gram-positive bacteria.[A190723] Like other semisynthetic tetracyclines, minocycline has modificati…

Kategori:
Agents Causing Muscle ToxicityAgents that produce neuromuscular block (indirect)Alimentary Tract and Metabolism +16
Target Protein:
30S ribosomal protein S930S ribosomal protein S416S ribosomal RNA +9
Waktu ParuhThe half life of mi…
Vol. DistribusiThe volume of distr…
KlirensIntravenous minocyc…
Genetik -
Minretumomab DB15470
biotech | CAS: 195189-17-4

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Miocamycin Approved DB13287
biotech | CAS: 55881-07-7

Miocamycin is a macrolide type antimicrobial [A176170]. This drug may be marketed in Japan for clinical use as it is listed in the Japanese pharmacopeia [L5737]. It has shown to be effective against several gram-positive and gram-negative microbes and may be …

Kategori:
Anti-Bacterial AgentsAnti-Infective AgentsAntibacterials for Systemic Use +9
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
MIP-1095 I-123 DB12994
small molecule | CAS: 949575-25-1

123 I Mip 1095 is under investigation in clinical trial NCT00712829 (Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
MIP-1095 I-131 DB14978
small molecule | CAS: 1258980-67-4

MIP-1095 I-131 is under investigation in clinical trial NCT03030885 (Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mipicoledine DB15075
small molecule | CAS: 942149-56-6

Mipicoledine is under investigation in clinical trial NCT01048008 (Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mipsagargin DB11813
small molecule | CAS: 1245732-48-2

Mipsagargin has been used in trials studying the treatment of Prostate Cancer, Prostatic Neoplasms, Advanced Solid Tumors, Glioblastoma Multiforme, and Hepatocellular Carcinoma, among others.

Target Protein:
Glutamate carboxypeptidase 2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mirabegron Approved DB08893
small molecule | CAS: 223673-61-8

Mirabegron is a sympathomimetic beta-3 adrenergic receptor agonist used to relax the smooth muscle of the bladder in the treatment of urinary frequency and incontinence. It is unique amongst overactive bladder treatment options in that, unlike other treatment…

Kategori:
Adrenergic AgentsAdrenergic AgonistsAdrenergic beta-3 Receptor Agonists +32
Target Protein:
Beta-3 adrenergic receptorBeta-1 adrenergic receptor
Waktu ParuhThe mean terminal e…
Vol. DistribusiFollowing intraveno…
KlirensTotal plasma cleara…
Genetik -
Miransertib DB14982
small molecule | CAS: 1313881-70-7

Miransertib is under investigation in clinical trial NCT01473095 (Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma).

Kategori:
AminesPyridines
Target Protein:
RAC-gamma serine/threonine-protein kinaseRAC-alpha serine/threonine-protein kinase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Miravirsen DB12851
biotech | CAS: 1072874-90-8

Miravirsen has been investigated for the treatment of Hepatitis C and Hepatitis C, Chronic.

Kategori:
Nucleic Acids, Nucleotides, and NucleosidesNucleotidesPolynucleotides
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mirdametinib DB07101
small molecule | CAS: 391210-10-9

PD-0325901 has been used in trials studying the treatment and basic science of Melanoma, Solid Tumour, Solid Tumors, Advanced Cancer, and Breast Neoplasms, among others.

Kategori:
Acids, CarbocyclicAmidesAmines +3
Target Protein:
Dual specificity mitogen-activated protein kinase kinase 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mirfentanil DB09175
small molecule | CAS: 117523-47-4

Mirfentanil is a derivative of fentanyl that presents high selectivity for the mu opioid receptor. At lower doses, it antagonizes the analgesic effects of alfentanil and substitutes for naloxone in morphine-treated monkeys; however, it also reverses naloxone-…

Kategori:
Piperidines
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Miricorilant DB16234
small molecule | CAS: 1400902-13-7

Miricorilant is under investigation in clinical trial NCT03818256 (Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adult Patients With Schizophrenia and Recent Weight Gain While Taking Antipsychotic Medication…

Kategori:
PyrimidinesPyrimidinones
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Miridesap DB13087
small molecule | CAS: 224624-80-0

Miridesap has been used in trials studying the prevention of HIV and treatment of AL amyloidosis.

Target Protein:
Serum amyloid P-component
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mirikizumab Approved DB14910
biotech | CAS: 1884201-71-1

Mirikizumab is a monoclonal antibody developed by Eli Lilly intended to treat ulcerative colitis. It inhibits the actions of interleukin-23 (IL-23), a pro-inflammatory cytokine that activates pathways contributing to the development of inflammatory diseases.[…

Kategori:
Amino Acids, Peptides, and ProteinsAnalgesicsAnti-Inflammatory Agents +16
Target Protein:
Interleukin-23 subunit alpha
Waktu ParuhThe geometric mean …
Vol. DistribusiThe geometric mean …
KlirensThe geometric mean …
Genetik -
Mirococept DB06492
biotech | CAS: 507453-82-9

Mirococept (APT070) is a complement inhibitor currently under development for treatment of rheumatoid arthritis and I/RI. It is a truncated form of the human Complement Receptor 1 (CR1) linked to a unique Prodaptin™ construct that regulates the over-productio…

Target Protein:
Complement C3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mirodenafil DB11792
small molecule | CAS: 862189-95-5

Mirodenafil has been used in trials studying the treatment and supportive care of Kidney Diseases, Urologic Diseases, Renal Insufficiency, Erectile Dysfunction, and Male Erectile Dysfunction.

Kategori:
AmidesEnzyme InhibitorsPhosphodiesterase 5 Inhibitors +5
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Miromavimab DB17803
biotech | CAS: 2247163-73-9

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mirtazapine Approved DB00370
small molecule | CAS: 85650-52-8

Mirtazapine is a tetracyclic _piperazino-azepine_ antidepressant agent that was initially approved for the treatment of major depressive disorder (MDD) in the Netherlands in 1994.[A177946] This drug was first manufactured by Organon Inc., and received FDA app…

Kategori:
Adrenergic AgentsAdrenergic alpha-2 Receptor AntagonistsAdrenergic alpha-Antagonists +38
Target Protein:
5-hydroxytryptamine receptor 2A5HT3 serotonin receptorAlpha-2A adrenergic receptor +4
Waktu Paruh20-40 hours [FDA la…
Vol. DistribusiThe volume of distr…
KlirensTotal body clearanc…
Genetik -
Mirvetuximab soravtansine Approved DB12489
biotech | CAS: 1453084-37-1

Mirvetuximab soravtansine-gynx (IMGN853) is an antibody-drug conjugate (ADC) formed by a monoclonal antibody (M9346A) that targets folate receptor alpha (FR?), covalently joined by a cleavable disulfide linker to the genotoxic compound DM4 (also known as sora…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +19
Target Protein:
Folate receptor alpha
Waktu ParuhAfter the first dos…
Vol. DistribusiMirvetuximab soravt…
KlirensThe total plasma cl…
Genetik -
Misetionamide DB18098
small molecule | CAS: 856785-75-6

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Misonidazole DB11716
small molecule | CAS: 13551-87-6

Misonidazole is under investigation in clinical trial NCT00038038 (Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole).

Kategori:
Anti-Infective AgentsAntineoplastic AgentsAntiparasitic Agents +5
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Misoprostol Approved DB00929
small molecule | CAS: 59122-46-2

Misoprostol is a prostaglandin analog used to reduce the risk of NSAID related ulcers, manage miscarriages, prevent post partum hemorrhage, and also for first trimester abortions.[L7616,L7619,A181589,A181583,A181697] The stimulation of prostaglandin receptors…

Kategori:
Abortifacient AgentsAbortifacient Agents, NonsteroidalAlimentary Tract and Metabolism +24
Target Protein:
Prostacyclin receptorProstaglandin E2 receptor EP3 subtypeProstaglandin E2 receptor EP2 subtype +2
Waktu ParuhThe half life of an…
Vol. DistribusiData regarding the …
KlirensBecause of the rapi…
Genetik -
Mitapivat Approved DB16236
small molecule | CAS: 1260075-17-9

Mitapivat is a novel, first-in-class pyruvate kinase activator. It works to increase the activity of erythrocyte pyruvate kinase, a key enzyme involved in the survival of red blood cells. Defects in the pyruvate kinase enzyme in various red blood cells disord…

Kategori:
Anemia, Hemolytic, Congenital, drug therapyBlood and Blood Forming OrgansCytochrome P-450 CYP1A2 Substrates +27
Target Protein:
Pyruvate kinase PKLRAromatase
Waktu ParuhIn patients with py…
Vol. DistribusiThe mean volume of …
KlirensPopulation pharmaco…
Genetik -
Mitazalimab DB15225
biotech | CAS: 2055640-86-1

Mitazalimab is under investigation in clinical trial NCT02379741 (ADC-1013 First-in-Human Study).

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mitemcinal DB06587
small molecule | CAS: 154738-42-8

Mitemcinal (GM-611) is a novel erythromycin-derived prokinetic agent that acts as an agonist at the motilin receptor.

Kategori:
Anti-Bacterial AgentsCytochrome P-450 CYP3A InhibitorsCytochrome P-450 CYP3A4 Inhibitors +5
Target Protein:
Motilin receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mitiglinide DB01252
small molecule | CAS: 145375-43-5

Mitiglinide is a drug for the treatment of type 2 diabetes. It may stimulate insulin secretion in beta-cells by closing off ATP dependant potassium ion channels.

Kategori:
Alimentary Tract and MetabolismBlood Glucose Lowering AgentsDrugs Used in Diabetes +4
Target Protein:
ATP-binding cassette sub-family C member 8ATP-sensitive inward rectifier potassium channel 10Peroxisome proliferator-activated receptor gamma
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mitiperstat DB18963
small molecule | CAS: 1933460-19-5

Mitiperstat is under investigation in clinical trial NCT05492877 (An Efficacy and Safety Study of Mitiperstat (AZD4831) (MPO Inhibitor) vs Placebo in the Treatment of Moderate to Severe COPD.).

Target Protein:
Myeloperoxidase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mitoglitazone DB11721
small molecule | CAS: 146062-49-9

Mitoglitazone has been used in trials studying the treatment of Type 2 Diabetes and Alzheimer's Disease.

Kategori:
Sulfur CompoundsThiazoles
Target Protein:
Insulin receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mitoguazone DB12967
small molecule | CAS: 459-86-9

Mitoguazone has been used in trials studying the treatment of Lymphoma, HIV Infections, and Lymphoma, Non-Hodgkin.

Kategori:
AmidinesAntineoplastic AgentsAntineoplastic and Immunomodulating Agents +2
Target Protein:
S-adenosylmethionine decarboxylase proenzyme
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mitometh DB12117
small molecule | CAS: 107465-03-2

Mitometh is under investigation for the treatment of Adenocarcinoma, Oropharyngeal Neoplasms, Nasopharyngeal Carcinoma, Non-small Cell Lung Cancer, and Stage IV Non-small Cell Lung Cancer, among others. Mitometh has been investigated for the treatment of Lung…

Kategori:
Hydrocarbons, ChlorinatedHydrocarbons, Halogenated
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mitomycin Approved DB00305
small molecule | CAS: 50-07-7

Mitomycin is an antineoplastic antibiotic first isolated by Japanese microbiologists in the 1950s from cultures of _Streptomyces caespitosus_.[L12867,A193419] It is an alkylating agent that inhibits DNA synthesis (and, at higher concentrations, RNA and protei…

Kategori:
Alkylating ActivityAlkylating DrugsAntibiotics, Antineoplastic +19
Target Protein:
DNA
Waktu Paruh8-48 min
Vol. Distribusi-
Klirens-
Genetik -
Mitomycin A DB19369
small molecule | CAS: 4055-39-4

Deskripsi belum tersedia.

Kategori:
AzirinesHeterocyclic Compounds, Fused-RingIndolequinones +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Menampilkan 7401–7450 dari 11778
Sebelumnya Halaman 149 / 236 Berikutnya